SOURCE: Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc.

September 10, 2010 08:00 ET

Sunwin International Neutraceuticals, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 14, 2010 at 5:45 p.m.

QUFU, CHINA--(Marketwire - September 10, 2010) -  Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), one of the top global providers of high quality stevia extracts including Rebaudioside A 98, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 14th, 2010. The Conference will be held September 12th-15th at The New York Palace Hotel in New York City. 

The Company's presentation will take place in the Kennedy I Salon at 5:45 p.m. and company representatives will participate in one-on-one meetings with analysts and investors throughout the three-day event. Mr. Richard Galterio, U.S. representative will present on behalf of the Company.

The Company will discuss the Company's performance to date as well as its growth plan for the future.

Participation is by invitation and registration is mandatory. For more information on the conference, contact a Rodman & Renshaw representative or visit:

http://www.RodmanandRenshaw.com/

About Rodman & Renshaw

Rodman & Renshaw Capital Group, Inc., through its subsidiaries, engages in investment banking business. It offers corporate finance services focusing on various public and private equity products, which include private investment in public equity, registered direct offerings, private placements, and public offerings, as well as provides Collateralized Acquisition Pool, a product used to facilitate a targeted acquisition. The company also provides strategic advisory services, which include identifying and evaluating acquisition targets or acquirers; providing valuation analyses; evaluating and proposing financial and strategic alternatives; rendering fairness opinions; advising on timing, structure, and pricing of transaction; assisting in negotiating and closing a transaction; advising on the sale process; and assisting in preparing a memorandum or other sales materials. In addition, it provides merchant banking and asset management services. The company is headquartered in New York, New York.

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. is a vertically integrated leader in the area of all natural, zero calorie stevia sweeteners in addition to the production and sale of essential traditional Chinese medicines prepared from 100 percent natural herbal ingredients. As an industry leader in stevia and herbal processing, Sunwin has built an integrated global firm with sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit: www.sunwininternational.com

Safe Harbor Statement

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations regarding our production capabilities, our production management capabilities, the success of our products, our competitive advantages and the creation of products that are superior tasting and commercially successful.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2010 and our reports on Form 10-Q.

Contact Information

  • Contact:

    Lillian Wong
    U.S. Representative
    954-363-7333